To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Aspirin reduces risk of recurrence in patients with unprovoked venous thromboembolism

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2013

Aspirin reduces risk of recurrence in patients with unprovoked venous thromboembolism

Vol: 2| Issue: 7| Number:580| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Aspirin for preventing the recurrence of venous thromboembolism

N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238

Contributing Authors:
C Becattini G Agnelli A Schenone S Eichinger E Bucherini M Silingardi M Bianchi M Moia W Ageno MR Vandelli E Grandone P Prandoni WARFASA Investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Two weeks following the completion of treatment with vitamin K antagonists, 403 patients with a previous unprovoked venous thromboembolism (VTE) were randomised into two groups. Patients either received 100 mg aspirin or a placebo, once per day for 2 years, to measure the recurrence of VTE. Following assessments every 3 months in the first year and every 6 months in the second year, the results de...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.

Continue